Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection

Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection

Abstract Introduction Recurrent Clostridioides difficile infection (rCDI) is common, with symptoms ranging from diarrhea to life-threatening sepsis. This study aimed to assess the real-world outcomes of patients with rCDI in the United States (US) who received fecal microbiota, live-jslm (RBL), the...

Full description

Saved in:
Bibliographic Details
Main Authors: Sahil Khanna, Sanghyuk Seo, Min Yang, Viviana Garcia-Horton, Yipeng Gao, Hannah H. Kim, Loren Ormenaj, Amy Guo
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-03-01
Series:Infectious Diseases and Therapy
Subjects:
Fecal microbiota live-jslm
RBL
Recurrent Clostridioides difficile infection
Online Access:https://doi.org/10.1007/s40121-025-01130-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items